Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies

Abhishek Abhishek, Matthew D Stevenson, Georgina Nakafero, Matthew J Grainge, Ian Evans, Oras Alabas, Tim Card, Maarten W Taal, Guruprasad P Aithal, Christopher P Fox, Christian D Mallen, Danielle A van der Windt, Richard D Riley, Richard B Warren, Hywel C Williams

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science